With a series of new products this year and the acquisition of Cosman Medical’s radiofrequency portfolio, Boston Scientific continues to drive forward as a leading provider of meaningful innovation for patients suffering from chronic pain. With over 200,000 patients implanted globablly, patient centric solutions and physician partnerships are integral to the company’s continued growth and innovation. This educational supplement provides a look at the pace of innovation from Boston Scientific Neuromodulation—from the latest products and clinical data to insights from key physicians from across Europe.
